Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
March 30, 2021
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma
Zhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, et al.
Cancers
|
November 13, 2021
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy
Diederick J van Doorn, Pim Hendriks, Mark C Burgmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2019
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
Tim A Labeur, Sarah Berhane, Julien Edeline, et al.
Scientific Reports
|
July 25, 2019
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Kostandinos Sideras, Robert A de Man, Susan M Harrington, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 9, 2024
Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals
Lesley A Patmore, Michelle Spaan, Kosh Agarwal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 22, 2021
Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course
Belle V van Rosmalen, Alicia Furumaya, Anne J Klompenhouwer, et al.
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 18, 2024
Preclinical targeting of liver fibrosis with a <sup>89</sup>Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β
Joey A Muns, Erik Schooten, Rychon D J van Dasselaar, et al.
JHEP Reports : Innovation in Hepatology
|
June 23, 2026
Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort
Koen C van Son, Kirsi M A van Eekhout, Judith de Vos-Geelen, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease
Lesley A Patmore, Ivana Carey, Jordan J Feld, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Cellular and Molecular Gastroenterology and Hepatology
|
March 30, 2021
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma
Zhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, et al.
Cancers
|
November 13, 2021
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy
Diederick J van Doorn, Pim Hendriks, Mark C Burgmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2019
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
Tim A Labeur, Sarah Berhane, Julien Edeline, et al.
Scientific Reports
|
July 25, 2019
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Kostandinos Sideras, Robert A de Man, Susan M Harrington, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 9, 2024
Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals
Lesley A Patmore, Michelle Spaan, Kosh Agarwal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 22, 2021
Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course
Belle V van Rosmalen, Alicia Furumaya, Anne J Klompenhouwer, et al.
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 18, 2024
Preclinical targeting of liver fibrosis with a <sup>89</sup>Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β
Joey A Muns, Erik Schooten, Rychon D J van Dasselaar, et al.
JHEP Reports : Innovation in Hepatology
|
June 23, 2026
Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort
Koen C van Son, Kirsi M A van Eekhout, Judith de Vos-Geelen, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease
Lesley A Patmore, Ivana Carey, Jordan J Feld, et al.
Page
of 11